Fonte: Acta dermato-venereologica. Unidade: FM
Assuntos: DERMATITE, CRIANÇAS, SINAIS E SINTOMAS
ABNT
WOLLENBERG, Andreas et al. Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis. Acta dermato-venereologica, v. 102, 2022Tradução . . Disponível em: https://doi.org/10.2340/actadv.v102.854. Acesso em: 23 ago. 2024.APA
Wollenberg, A., Marcoux, D., I, J. S., Aoki, V., Baselga, E., Zhang, H., et al. (2022). Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis. Acta dermato-venereologica, 102. doi:10.2340/actadv.v102.854NLM
Wollenberg A, Marcoux D, I JS, Aoki V, Baselga E, Zhang H, Levit NA, Taieb A, Rossi AB. Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis [Internet]. Acta dermato-venereologica. 2022 ; 102[citado 2024 ago. 23 ] Available from: https://doi.org/10.2340/actadv.v102.854Vancouver
Wollenberg A, Marcoux D, I JS, Aoki V, Baselga E, Zhang H, Levit NA, Taieb A, Rossi AB. Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis [Internet]. Acta dermato-venereologica. 2022 ; 102[citado 2024 ago. 23 ] Available from: https://doi.org/10.2340/actadv.v102.854